Articles

Page 13 of 19

Cost-minimisation analysis of the use of etravirine or raltegravir in treatment-experienced HIV-1-infected patients

Authors: S Martin and E Smets

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P316

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Cost-effectiveness analysis of HLA-B*5701 screening in preventing abacavir hypersensitivity in Spain

Authors: D Nieves, O de la Calle, JA Iribarren, A Rivero, L García-Bujalance, I Pérez-Escolano and M Brosa

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P314

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Economic modeling of the combined effects of HIV disease, heart disease and lipoatrophy based on ACTG 5142 trial data

Authors: KN Simpson, R Rajagopalan, B Dietz, K Garren, S Riddler and R Haubrich

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P312

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
An economic evaluation of using raltegravir in treatment-experienced HIV-1 infected patients in the UK

Authors: E Elbasha, W Dunlop, MA Chaudhary and RN Kumar

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P310

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
96 weeks pharmacoeconomic outcome of lopinavir/r monotherapy as maintenance strategy in HIV+ patients with suppressed viral load. OK04-PharmECO analysis

Authors: JR Arribas, F Pulido, I Méndez, P Lázaro, M Norton, E Cabrero and A Burgos

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P308

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Outcome of chronic hepatitis delta in patients with and without HIV infection in the HAART era

Authors: P Tuma, E Vispo, P Barreiro, A Madejon, J Medrano, R Romero, M Bottecchia, J García-Samaniego and V Soriano

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P284

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Hepatic tolerability of fosamprenavir/ritonavir (FPV/RTV) in HIV/hepatitis C co-infected subjects with severe hepatic fibrosis

Authors: P Nasta, F Gatti, G Cologni, A Matti, M Monia and G Carosi

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P282

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Abstract withdrawn

Authors:

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P280

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Efficacy of shorter duration HCV treatment in injection drug users (IDUs)

Authors: A Barrieshee and B Conway

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P278

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Continuing evidence to support the role of early kinetic monitoring in predicting sustained viral response for HIV/HCV co-infected patients

Authors: J Kieran, A Jackson, DO Shea, G Farrell, J Thornhill, C McNally, F Mulcahy and C Bergin

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P276

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation

Authors: J Ng, CE Klein, P Diderichsen, BA Da Silva, B Bernstein, WM Awni and YL Chui

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P245

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Atazanavir (ATV) plasma concentrations at different times after drug uptake: associations with virologic response and hyperbilirubinemia

Authors: M Fabbiani, S Di Giambenedetto, E Ragazzoni, M Colafigli, M Prosperi, R Cauda, P Navarra and A De Luca

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P243

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
The pharmacokinetic (PK) interaction between omeprazole and TMC278, an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI)

Authors: HM Crauwels, RPG van Heeswijk, D Kestens, M Stevens, A Buelens, K Boven and RMW Hoetelmans

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P239

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Frequency of functional drug disposition gene polymorphism in Thai population: relevance to antiretroviral drugs

Authors: A Chaikan, N Chierakul, N Saguenwong, C Chuchuttaworn, A Owen, L Dickinson, SH Khoo, DJ Back and GR Davies

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P237

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Measurement of 3-methylhistidine in spot urine from HIV-infected persons: an alternative screening method for muscle protein degradation to serum CK

Authors: AC Venhoff, E Bissé, T Epting, J Thoden, UA Walker and N Venhoff

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P210

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Effect of hemolysis on HIV-1 protease and reverse transcriptase genotyping and phenotyping success: a 2-year analysis

Authors: T Pattery, I Bovee, E Rousseau, N Hartmans and P Mc Kenna

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P208

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients

Authors: R Maserati, M Clerici, M Lauriola, M Pacei, M De Gennaro, E Chiesa, M Coen, R Terzi, DH Bray and S Lo Caputo

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P206

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Influence of gender in predicting CCR5 coreceptor usage

Authors: S Nozza, A Soria, F Visco, C Vinci, F Cossarini, V Spagnuolo, B Barda, L Della Torre, A Castagna, A Lazzarin, L Galli and G Tambussi

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P202

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Depression in HIV patients is associated with low adherence: a cross-sectional study among HIV patients in Denmark

Authors: LO Rodkjaer, T Laursen, N Balle and M Sodemann

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P174

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Challenges to adherence among HIV-positive patients on antiretroviral therapy in Lagos, Nigeria

Authors: AO Adeyemi, OO Olaogun and OA Adesola

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P172

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Adherence with lopinavir/ritonavir (LPV/r) tablet and SoftGel (SGC) capsule based antiretroviral regimens and predictors of early treatment compliance

Authors: TJ Podsadecki, RA Rode, C Naylor, DE Cohen and TM Marsh

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P170

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Once-daily regimens were associated with a higher rate of self-chosen discontinuations

Authors: R Murri, A Cingolani, A De Luca, S Di Giambenedetto, G Marasca, A Muscatello, V Mazzocato, L Bracciale and E Tamburrini

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P168

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Relationship between different types of non-adherence behaviour and virological response in unselected HIV-positive cohort

Authors: A Ammassari, MP Trotta, P Marconi, M Zaccarelli, P Sette, ML Giancola, P Pierro, S Mosti, RA Acinapura and A Antinori

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P166

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Hepatic safety of tipranavir/ritonavir (TPV/r)-based antiretroviral therapy: effect of hepatitis virus co-infection and baseline liver fibrosis

Authors: J Macias, F Orihuela, A Rivero, P Viciana, M Márquez, J Portilla, MJ Ríos, L Muñoz, J Pasquau, M Castaño, L Abdel-Kader and JA Pineda

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P141

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Risk factors for advanced liver fibrosis in HIV-infected individuals: role of the metabolic syndrome

Authors: F Blanco, P Barreiro, P Ryan, E Vispo, L Martin-Carbonero, P Tuma, P Labarga, J González-Lahoz and V Soriano

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P137

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Screening for liver fibrosis in HIV-mono-infected patients with increased ALT comparing FibroScan with FIB-4

Authors: S Mauss, J Henke, F Berger, P Hegener and G Schmutz

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P135

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Evaluation of kidney toxicity in HIV patients with tenofovir-based regimen: the role of boosted protease inhibitor in real clinical setting

Authors: F Ortu, P Piano, P Serra, R Meleddu, N Corso and PE Manconi

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P133

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
A central body fat distribution is related to increased renal arterial resistance index and renal function impairment in HIV-1 infected patients

Authors: PF Grima, P Grima and R Chiavaroli

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P131

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
A cross-sectional comparison of renal function in patients on stable abacavir (ABC) or tenofovir (TDF) containing therapy

Authors: LJ Waters, P Randell, AGA Jackson, J Taylor, S Mandalia, BG Gazzard and GJ Moyle

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P129

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Prevalence of cardiovascular risk factors (CRF) and metabolic syndrome (MS) in a cohort of HIV-infected patients in southern Spain. PREGO study

Authors: M Gallego, F Oñate, A del Arco, J Roldan, M Grana, R Palacios and J Santos

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P102

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Contribution of antiretroviral therapy, cardiovascular risk factors and constituents of metabolic syndrome to insulin resistance(IR) in HIV

Authors: M Cervero Jiménez, R Torres Perea, JL Agud Aparicio, JJ Jusdado Ruiz-Capillas, C García Lacalle, M del Álamo Rodríguez and E García Benaya

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P100

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Safety personalisation of ART therapy: what treatments do patients receive with the knowledge of their HLA-B*5701 status?

Authors: R Rubio, MA Johnson, BJ Haas, EA Loeschel, C Granier, F Jackson and HC Pearce

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P83

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Real-life effectiveness and safety of lopinavir/ritonavir in HIV-infected adults who experienced prior different antiretroviral treatments

Authors: B Conway, J DeWet, A Tsang, K Logue, C Kovacs, N Ackad, J Vaillancourt, N Longo, D Haine and JS Sampalis

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P81

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam

Authors: VT Tuyet Nhung, D Colby, H Thu Thuy, L Vinh Thuy, DT Nhat Vinh and L Truong Giang

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P77

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Use of lopinavir/ritonavir in first-line therapy or second-line therapy: 48-week results from the German prospective STAR cohort

Authors: C Koegl, A Trein, W Schmidt, A Baumgarten, H Jaeger and HJ Stellbrink

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P75

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Use of traditional complementary and alternative medicine (TCAM) by HIV patients prior to initiating ART in KwaZulu-Natal, South Africa

Authors: K Peltzer, N Friend-du Preez, S Ramlagan, H Fomundam and J Anderson

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P73

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Positive predictive factors in HIV-1 patients treated with enfuvirtide plus an OB that include an active boosted PI. Preliminary FastFuz study results

Authors: E Ribera, A Antela, JA Garcia Henarejos, JR Arribas, JA Oteo, M Lopez Gomez and E Ferrer

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P44

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Exposition and sequencing to antiretrovirals in HIV-1 patients with triple-class antiretroviral failure, and harbouring protease resistance mutations

Authors: JM Llibre, P Domingo, F Blanco, B Clotet, A Ocampo, JA García-Henarejos, P Geijo, C Rosa, J Hernandez-Quero and A Castro

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P42

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Raltegravir, etravirine and darunavir-ritonavir: a safe and successful rescue regimen in highly treatment-experienced HIV1-infected patients

Authors: A Imaz, S Villar del Saz, MA Rivas, A Curran, E Caballero, V Falco, M Crespo, I Ocana, M Diaz, E Ruiz de Gopegui, M Riera and E Ribera

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P40

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Efficacy and safety of an antiretroviral regimen containing etravirine plus raltegravir in HIV-1 treatment-experienced patients failing darunavir

Authors: A Canestri, C Blanc, M Wirden, G Peytavin, N Ktorza and C Katlama

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P38

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Antiretroviral treatment use and HIV-RNA suppression rates for 877 European patients in the etravirine expanded access programme

Authors: E Florence, S De Wit, A Castagna, E Ribera, AM Hill, R Ryan, H Vanaken, S Marks and Y van Delft

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P36

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
O324 HIV, immune deficiency and malignancy

Authors: AE Grulich

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O34

Content type: Oral presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
O322 Bone disease and HIV – together for the long term

Authors: P Mallon

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O32

Content type: Oral presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
O312 Cardiovascular disease; HIV, ART, immunodeficiency, pro-inflammation and other factors

Authors: JD Lundgren

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O28

Content type: Oral presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Evaluating affordable screening markers to detect HIV-1-infected Ugandan adults with CD4 counts of less than 200 cells/mul

Authors: GM Miiro, J Todd, S Nakubulwa, C Watera, P Hughes, P Munderi, S Floyd and H Grosskurth

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P11

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz

Authors: RJ Bedimo, H Drechsler, M Holodniy, M Pasley and W Woodward

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P9

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
O124 Efavirenz and rifampicin in the South African context: is there a need to dose increase efavirenz with concurrent rifampicin therapy?

Authors: C Orrell, K Cohen, P Ive, I Sanne and R Wood

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O9

Content type: Oral presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Similar virological response rates for ART-naïve subjects starting KVX + LPV/r or TVD+ LPV/r. Data from the prospective observational STAR cohort

Authors: E Wolf, A Trein, W Schmidt, A Baumgarten, H Jaeger and HJ Stellbrink

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P7

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Effects of NRTI backbone on HIV RNA, CD4 counts and lipids for first-line boosted PI-based HAART: meta-analysis of 12 clinical trials in 4,896 patients

Authors: AM Hill and WA Sawyer

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P5

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Impact of antiretroviral dosing and daily pill burden on viral rebound rates in naive patients receiving a tenofovir-based regimen

Authors: A Ammassari, P Lorenzini, F Maggiolo, G Sterrantino, A Corpolongo, G Rizzardini, N Abrescia, A Chirianni, M Foggia, C Mussini, N Gianotti, M Andreoni, CF Perno and A Antinori

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P3

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Journal of the International AIDS Society